Delivery Order SPE2DB20D9331-SPE2DB25FL0Z9

Award Date 3/24/25
Potential Completion Date 4/14/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nexplanon 68 mg implants. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,429.38 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, with a period of performance through May 2, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $6,837.40 and a period of performance through May 8, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999, which allows the DLA to...
The Defense Logistics Agency (DLA) awarded a $3,573.45 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4566185877 NEXPLANON 68 MG implants and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,440.70, is for the procurement of NEXPLANON 68 MG IMPLANTS with a completion date of September 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,165.86 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has a completion date of June 6, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in providing a comprehensive range of medical products, including branded and generic...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,418.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of January 27, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product, with a period of performance through December 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $7,146.90 contract is for the supply of NEXPLANON 68 MG IMPLANTS to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0Z9
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,471.55 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of April 14, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

Generated 6/29/25, 1:16 AM